BRRx Clinical Inc. and mCig Reveal Plans Begin Sales Of CBD Enhanced Foods

BRRx Clinical Inc. and mCig Reveal Plans Begin Sales Of CBD Enhanced Foods

BRRx Clinical Inc. and mCig Reveal Plans Begin Sales Of CBD Enhanced Foods

mCig and BRRx Clinical Inc. have announced that they are bringing new CBD enhanced products to the market and these will help in the treatment of shingles, herpes and liver disease. mCig and BRRx Clinical Inc. are set to act on an LOI to make a national independent compounding pharmacy network available.

The new products which are CBD Enhanced Medical Foods/topical applications will be unveiled by BRRx Clinical. The products, however, are currently in FDA trials undergoing several tests to confirm their authenticity and safety. According to reports, the CBD products are registered with the International Review Board. The first supplies by BRRx will be for the treatment of shingles. The topical application will be used alongside the medical foods and will work to relieve the pain that comes with diagnosis.

When developing the CBD enhanced product, the manufacturer said that it aimed to relieve the pain that is frequently associated with the disease and to deliver a trajectory for reversal of its diagnosis. The CEO of BRRx Clinical, Dale Hipes says that they are following a very strategic and well-thought-out plan by the company’s senior management team. “We are always seeking opportunities to affect change. We want to be the standard for the new Healthcare modalities that CBD based treatments bring to the marketplace,” Mr. Hipes said.

On his part, the CEO of mCig, Inc., Paul Rosenberg said that Dale Hipes completely changed his view of the cannabis industry as well as what the company should do to stay ahead of its competitors. He added that in a few weeks, they will be introducing their revolutionary BRRx Clinical web portal. This will allow them to offer some unique CBD products to consumers and these products are sure to enhance the quality of life of users. Shingle is a disease that very often affects those older than 50. It is said to be the reactivation of the chickenpox virus in the body. Shingles and chickenpox are caused by the varicella-zoster virus. Shingles usually cause painful rashes on one side of the body. Both those who have had chickenpox in the past and those who haven’t can develop this skin condition.

Medical experts are not sure of what reactivates the virus but old age is said to increase a person’s risk of developing shingles. Unlike chickenpox, shingles cannot be passed from one person to another. While the skin disease is not contagious, a person with active shingles can spread the varicella-zoster virus and cause chickenpox in someone who has not been vaccinated or who has never had chickenpox. Shingles is not a life-threatening disease but it can lead to serious problems such as blindness. With proper treatment, the condition can be resolved with days or weeks. Once the FDA gives its approval, the CBD enhanced medical foods will help to treat shingles in American adults and eliminate the aftermath of the d

isease.

The collaboration between mCig Inc. and BRRx Clinical will see to the release of other CBD products such as those for the treatment of herpes and liver disease. For now, however, they BRRx Clinical has said it will first release foods for the treatment of shingles before it moves on to others.